Table 1.
Empirical probabilities of rejecting H0 in simulated trials with 2 interim reviews (at times T1 and T2) and the final analysis (at time T3)
Scenario B |
Scenario C |
|||||||
Procedure | T1 | T2 | T3 | Overall | T1 | T2 | T3 | Overall |
MRCB | 0.139 | 0.559 | 0.222 | 0.920 | 0.679 | 0.259 | 0.038 | 0.976 |
GST16 | 0.120 | 0.432 | 0.131 | 0.683 | 0.088 | 0.311 | 0.142 | 0.541 |
GST24 | 0.142 | 0.668 | 0.160 | 0.970 | 0.008 | 0.018 | 0.026 | 0.052 |
WSL1 | 0.163 | 0.498 | 0.187 | 0.848 | 0.340 | 0.211 | 0.061 | 0.612 |
WSL2 | 0.699 | 0.298 | 0.003 | 1.00 | 0.190 | 0.015 | 0.053 | 0.258 |
WSL3 | 0.284 | 0.709 | 0.007 | 1.00 | 0.143 | 0.082 | 0.078 | 0.303 |
MRCB: multivariate repeated confidence bands approach with weight An(·;Tk) and the max-norm. GST16 and GST24: group sequential procedures based on Hotelling's T2 test on response at weeks 16 and 24. WSL1, WSL2, and WSL3: extensions of the approach of Wei and others with linear means, using the identity, the true, or the pooled sample covariance matrices.